The purpose of this study was to prospectively investigate the local concentrations of VEGF and angiogenin in the part of the lung, affected by a lung cancer and compare them by the healthy side of the lung and by the concentrations in the serum of patients with lung cancer. The gene discussed is VEGFA; the disease is lung cancer.